Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase II contract was awarded to Phrixus Pharmaceuticals, Inc. for $958,924.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI069598-02 | Phase II | 958,924 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $277,646.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK080551-01 | Phase I | 277,646 | ||||||||
A STTR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $226,675.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI069598-01 | Phase I | 226,675 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $622,877.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL110464-01A1 | Phase I | 622,877 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $153,916.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI088846-01 | Phase I | 153,916 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $379,487.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL095177-01 | Phase I | 379,487 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $215,084.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL088813-01 | Phase I | 215,084 | ||||||||
A STTR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $275,497.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI073072-01A1 | Phase I | 275,497 | ||||||||
A STTR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $306,708.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HL104893-01 | Phase I | 306,708 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $583,225.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS070327-01A1 | Phase I | 583,225 | ||||||||
A SBIR Phase I contract was awarded to Phrixus Pharmaceuticals, Inc. for $101,684.0 USD from the National Science Foundation. | SBIR | 0945221 | Phase I | 101,684 |